(SNN) Quote

JUST.......WELL WRITTEN!! GLTA!!

In regards to ACC RH has misled retail investors since 2017. Best the company shut up until concrete results.

Price is only holding in the crappy low .002s down 90% from .021 because most are so far underwater it makes no sense to sell and take a huge loss.

Frank, does the company need to initially fund some building improvements prior to release of WV funds. If so any guesstimate how much?

Agree the new contact announced is extremely important. I would assume the contractor needs to sign off on any advances.

With respect to Teoxane's Change of Control provision, it's immaterial whether the Crown-RVNC deal is characterized as a merger or an acquisition. Regardless, the deal plainly involves a change of control.

I understand you sold and have FOMO. Nobody’s gonna sell to you at 3’s. This $idvv play is a .0005-.001 play. Plain and simple.

$6s It’s getting a nuclear pump Constellation Energy and Microsoft going radioactive soon

Oops
https://x.com/visegrad24/status/1838275605571219618?s=19

Btw, at the very end of the Tempest Therapeutics BBS interview the CEO (yes, that's right the CEO) says no compassionate use when going for Plll FDA approval.

Credit Suisse............. glad I'm out of that dump UBS. They still have one stock holding they bought for me as an OTC. Now they can't seem to find the purchase records when my account was transferred from Morgan Stanley to UBS as my accounts were transferred. Nobody will take these shares of this

A Likely scenario. Where's the volume.

Looks like we got a buyer accumulating some shares today.
Nice to see the stair-step upwards...!
Maybe some news is getting put together!!!

Actually that's an interesting question. GS took the trouble and expense to change the names of both GVSI and WNFT with the hopes of attracting a suitor. He might have also had a comprehensive strategy of attracting multiple companies, since he opted for the term, 'Global'/'World-Wide' in their resp

Actually that's an interesting question. GS took the trouble and expense to change the names of both GVSI and WNFT with the hopes of attracting a suitor. He might have also had a comprehensive strategy of attracting multiple companies, since he opted for the term, 'Global'/'World-Wide' in their resp

Actually that's an interesting question. GS took the trouble and expense to change the names of both GVSI and WNFT with the hopes of attracting a suitor. He might have also had a comprehensive strategy of attracting multiple companies, since he opted for the term, 'Global'/'World-Wide' in their resp

MARA dip bought

All sells today, must be slingshot effect. No ticker change or uplisting news, just another useless Xpost today about DC meeting. Really nothing to get excited about. The droll troll has spoken.

All sells today, must be slingshot effect. No ticker change or uplisting news, just another useless Xpost today about DC meeting. Really nothing to get excited about. The droll troll has spoken.

Actually that's an interesting question. GS took the trouble and expense to change the names of both GVSI and WNFT with the hopes of attracting a suitor. He might have also had a comprehensive strategy of attracting multiple companies, since he opted for the term, 'Global'/'World-Wide' in their resp

Actually that's an interesting question. GS took the trouble and expense to change the names of both GVSI and WNFT with the hopes of attracting a suitor. He might have also had a comprehensive strategy of attracting multiple companies, since he opted for the term, 'Global'/'World-Wide' in their resp

All sells today, must be slingshot effect. No ticker change or uplisting news, just another useless Xpost today about DC meeting. Really nothing to get excited about.

Vix 15.87 still Boss ?

Change of control filing out today if anyone cares lol https://www.otcmarkets.com/otcapi/company/financial-report/412971/content

IMHO, Elite has absolutely no reason to partner with Purdue (Knoa) And vice versa. They have no reason to partner with us. Each company has their own manufacturing capabilities. As one of the first few generics the product will practically market itself. Knoa (Purdue) might want to sell the produ

No thanks.